These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12902196)

  • 1. Evaluation of nonthreshold leukemogenic response to methyl nitrosourea in p53-deficient C3H/He mice.
    Hirabayashi Y; Yoshida K; Aizawa S; Kodama Y; Kanno J; Kurokawa Y; Yoshimura I; Inoue T
    Toxicol Appl Pharmacol; 2003 Aug; 190(3):251-61. PubMed ID: 12902196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzene-induced hematopoietic neoplasms including myeloid leukemia in Trp53-deficient C57BL/6 and C3H/He mice.
    Kawasaki Y; Hirabayashi Y; Kaneko T; Kanno J; Kodama Y; Matsushima Y; Ogawa Y; Saitoh M; Sekita K; Uchida O; Umemura T; Yoon BI; Inoue T
    Toxicol Sci; 2009 Aug; 110(2):293-306. PubMed ID: 19478238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 (TRP53) deficiency-mediated antiapoptosis escape after 5 Gy X irradiation still induces stem cell leukemia in C3H/He mice: comparison between whole-body assay and bone marrow transplantation (BMT) assay.
    Yoshida K; Hirabayashi Y; Wada S; Watanabe F; Watanabe K; Aizawa S; Inoue T
    Radiat Res; 2007 Jun; 167(6):703-10. PubMed ID: 17523849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of connexin 32 in steady-state hematopoiesis, regeneration state, and leukemogenesis.
    Hirabayashi Y; Yoon BI; Tsuboi I; Huo Y; Kodama Y; Kanno J; Ott T; Trosko JE; Inoue T
    Exp Biol Med (Maywood); 2007 May; 232(5):700-12. PubMed ID: 17463168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the transgenic p53+/- mouse for detecting genotoxic liver carcinogens in a short-term bioassay.
    Dass SB; Bucci TJ; Heflich RH; Casciano DA
    Cancer Lett; 1999 Aug; 143(1):81-5. PubMed ID: 10465341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies evaluating the utility of N-methyl-N-nitrosourea as a positive control in carcinogenicity studies in the p53+/- mouse.
    Hoivik DJ; Allen JS; Wall HG; Nold JB; Miller RT; Santostefano MJ
    Int J Toxicol; 2005; 24(5):349-56. PubMed ID: 16257854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial transplantation of p53-deficient hemopoietic progenitor cells to assess their infinite growth potential.
    Hirabayashi Y; Matsuda M; Aizawa S; Kodama Y; Kanno J; Inoue T
    Exp Biol Med (Maywood); 2002 Jul; 227(7):474-9. PubMed ID: 12094011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Friend leukemia virus infection enhances DNA damage-induced apoptosis of hematopoietic cells, causing lethal anemia in C3H hosts.
    Kitagawa M; Yamaguchi S; Hasegawa M; Tanaka K; Sado T; Hirokawa K; Aizawa S
    J Virol; 2002 Aug; 76(15):7790-8. PubMed ID: 12097591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem-cell leukemia: p53 deficiency mediated suppression of leukemic differentiation in C3H/He myeloid leukemia.
    Yoshida K; Aizawa S; Watanabe K; Hirabayashi Y; Inoue T
    Leuk Res; 2002 Dec; 26(12):1085-92. PubMed ID: 12443880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesis.
    Yamamoto M; Tsukamoto T; Sakai H; Shirai N; Ohgaki H; Furihata C; Donehower LA; Yoshida K; Tatematsu M
    Carcinogenesis; 2000 Oct; 21(10):1891-7. PubMed ID: 11023548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic neoplastic diseases develop in C3H/He and C57BL/6 mice after benzene exposure: strain differences in bone marrow tissue responses observed using microarrays.
    Inoue T; Hirabayashi Y
    Chem Biol Interact; 2010 Mar; 184(1-2):240-5. PubMed ID: 20018183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
    van Steeg H; de Vries A; van Oostrom CTh ; van Benthem J; Beems RB; van Kreijl CF
    Toxicol Pathol; 2001; 29 Suppl():109-16. PubMed ID: 11695546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of hormonal carcinogenesis in the p53+/- hemizygous knockout mouse: studies with diethylstilbestrol.
    Carmichael PL; Mills JJ; Campbell M; Basu M; Caldwell J
    Toxicol Pathol; 2001; 29 Suppl():155-60. PubMed ID: 11695552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity and carcinogenicity studies of chlorpromazine hydrochloride and p-cresidine in the p53 heterozygous mouse model.
    Petruska JM; Frank DW; Freeman GB; Evans EW; MacDonald JS
    Toxicol Pathol; 2002; 30(6):696-704. PubMed ID: 12512871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of cancer-related pathways in primary hepatocytes derived from DNA repair-deficient Xpa-/-p53+/- mice upon exposure to benzo[a]pyrene.
    van Kesteren PC; Zwart PE; Pennings JL; Gottschalk WH; Kleinjans JC; van Delft JH; van Steeg H; Luijten M
    Toxicol Sci; 2011 Sep; 123(1):123-32. PubMed ID: 21715664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MGMT expression in murine bone marrow is a major determinant of animal survival after alkylating agent exposure.
    Reese JS; Qin X; Ballas CB; Sekiguchi M; Gerson SL
    J Hematother Stem Cell Res; 2001 Feb; 10(1):115-23. PubMed ID: 11276365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated susceptibility of the p53 knockout mouse esophagus to methyl-N-amylnitrosamine carcinogenesis.
    Shirai N; Tsukamoto T; Yamamoto M; Iidaka T; Sakai H; Yanai T; Masegi T; Donehower LA; Tatematsu M
    Carcinogenesis; 2002 Sep; 23(9):1541-7. PubMed ID: 12189199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous p53-deficient mice are not susceptible to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) carcinogenicity.
    Park CB; Kim DJ; Uehara N; Takasuka N; Hiroyasu BT; Tsuda H
    Cancer Lett; 1999 May; 139(2):177-82. PubMed ID: 10395176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance?
    van Kesteren PC; Beems RB; Luijten M; Robinson J; de Vries A; van Steeg H
    Carcinogenesis; 2009 Mar; 30(3):538-43. PubMed ID: 19136475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice.
    Kawate H; Itoh R; Sakumi K; Nakabeppu Y; Tsuzuki T; Ide F; Ishikawa T; Noda T; Nawata H; Sekiguchi M
    Carcinogenesis; 2000 Feb; 21(2):301-5. PubMed ID: 10657972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.